Ohio Is About to Have the Most Complicated Open Enrollment in Years — Cleveland Clinic, Two Carriers Leaving, and 16% Rate Hikes

Cleveland Clinic and Anthem Blue Cross are in contract dispute, risking out-of-network status for 113,000 Ohioans. Two carriers, CareSource and Molina, are exiting Ohio's individual market, affecting 54,000. Remaining insurers are raising rates by up to 24.1%. Open enrollment is complicated by these changes.

Original reporting
Published Oct 23, 2026, 10:15 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 23, 2026, 3:17 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Ohio Is About to Have the Most Complicated Open Enrollment in Years — Cleveland Clinic, Two Carriers Leaving, and 16% Rate Hikes — source image
Decision brief

The 30-second read

$OSCRBearishMed
01

Why it matters

The combined effect of network uncertainty and rate increases may shift enrollment patterns, influencing insurer revenue forecasts.

02

Market read

The dispute and rate hikes create immediate enrollment risk for insurers, prompting potential short‑term price adjustments.

03

What to watch

Potential regulatory intervention or negotiated settlements before year‑end may mitigate the worst‑case impact.

Relevance 5/10Novelty 6/10Timing: before Dec 31 deadline and open enrollment closing Jan 15

Background

Ohio's open enrollment period is complicated by a major network dispute and steep premium hikes across multiple carriers.

Company-level read

Ticker impact

$OSCRBearishMedium confidence
Context

Oscar Health, Ohio's largest individual market insurer, raises rates by 18% for 77,500 members.

Expected impact

potential pressure as market evaluates enrollment risk

Evidence & confidence

Large member base facing steep price rise creates enrollment uncertainty.

Market effects

Highlights rising cost pressures across the health‑insurance sector, potentially prompting broader premium‑price scrutiny.

Ohio's insurance market faces reduced carrier options and higher premiums, affecting local enrollment dynamics.

U.S. health‑insurance pricing trends may influence investor sentiment toward the sector worldwide.

Counterpoint

Rate hikes could improve profitability margins for insurers despite enrollment losses.

Key entities

  • Cleveland Clinic

    Large nonprofit hospital system at risk of losing in‑network status with Anthem.

  • Anthem

    Brand of Elevance Health (ELV) facing contract negotiations with Cleveland Clinic.

  • UnitedHealthcare of Ohio

    Provider of Ohio individual market plans with a 24.1% rate increase.

  • Oscar Health

    Ohio's largest individual market insurer raising rates by 18%.

Related articles

$OSCRMed

OSCR Maintained by UBS -- Price Target Raised to $36

UBS maintained a 'Neutral' rating for Oscar Health (OSCR) but raised its price target to $36 from $26. GuruFocus values OSCR at $24.66, suggesting it is 37.9% overvalued at $34.01. The company has a GF Score of 81/100, with strong growth and momentum but concerns over valuation and profitability. Insiders have sold $26.76M in shares over the past three months.

$OSCRHighAI 8/10

OSCR Looks 33.9% Overvalued on GF Value™ as Oscar Health Revises

Oscar Health (OSCR) revised its 2026 forecasts, raising operating earnings outlook by $100M to $600M-$800M and improving medical loss ratio guidance. Revenue guidance remains $18.7B-$19B. GF Value™ indicates OSCR is 33.9% overvalued at $32.44. The company has a strong GF Score™ of 83/100, with high growth and momentum ratings but middling profitability and valuation. Insiders have sold significantly more shares than they've bought.

$OSCRHighAI 8/10

Oscar Health boosts 2026 earnings outlook, affirms revenue

Oscar Health (OSCR) updated its 2026 earnings outlook, lowering its Medical Loss Ratio to 81.0%-82.0% and raising earnings from operations to $600M-$800M. The company reaffirmed revenue guidance of $18.7B-$19.0B and maintained SG&A expense ratio targets. The updates will be discussed at its 2026 Investor Day on September 16, 2026.